Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT04304209Phase 2Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2019
- Primary completion
- Oct 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in rectal cancer, sponsored by Sun Yat-sen University. Started Oct 2019; status: active, not recruiting.
02
Drugs
sintilimab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT04304209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04304209.